A new report by a major US cancer charity has found that uninsured Americans are less likely to survive cancer, less likely to be screened for it, and more likely to have an advanced stage of the disease once they are diagnosed, compared with Americans on health insurance.
The study, which examines the link between health insurance status and cancer treatment and survival, will appear in the January-February edition of the journal CA: A Cancer Journal for Clinicians and is the work of researchers from the American Cancer Society (ACS), led by Dr Elizabeth Ward, managing director, surveillance research at the ACS.
Other studies have already suggested that Medicaid and uninsured patients are more likely to be diagnosed with cancers that are more advanced, mostly because they can't afford to buy preventative services such as cancer screening.
This report from the ACS takes a closer look at the link between insurance status and cancer care, and takes into account a number of demographic, race, and socioeconomic factors.
Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts
Friday, December 21, 2007
Lack of health insurance kills
Via Echidne, Medical News Today reports:
Labels:
Cancer,
Health Care,
Health Insurance
Tuesday, April 24, 2007
Natural Antioxidant Selectively Kills Leukemia Cells
Science Daily:
A naturally occurring compound found in many fruits and vegetables as well as red wine, selectively kills leukemia cells in culture while showing no discernible toxicity against healthy cells, according to a study by researchers at the University of Pittsburgh School of Medicine. These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
"Current treatments for leukemia, such as chemotherapy and radiation, often damage healthy cells and tissues and can produce unwanted side effects for many years afterward. So, there is an intensive search for more targeted therapies for leukemia worldwide," said corresponding author Xiao-Ming Yin, M.D., Ph.D., associate professor of pathology, University of Pittsburgh School of Medicine.
Labels:
Cancer
Subscribe to:
Posts (Atom)